2,136
Views
1
CrossRef citations to date
0
Altmetric
Coronaviruses

Correlations of Myeloperoxidase (MPO), Adenosine deaminase (ADA), C–C motif chemokine 22 (CCL22), Tumour necrosis factor alpha (TNFα) and Interleukin-6 (IL-6) mRNA expression in the nasopharyngeal specimens with the diagnosis and severity of SARS-CoV-2 infections

, , , , , ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Article: 2157338 | Received 08 Sep 2022, Accepted 06 Dec 2022, Published online: 02 Jan 2023

References

  • WHO. WHO Coronavirus (COVID-19) dashboard. Available from: https://covid19.who.int/.
  • Chan JF, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514–523.
  • To KK, Sridhar S, Chiu KH, et al. Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic. Emerg Microbes Infect. 2021;10(1):507–535.
  • Gustine JN, Jones D. Immunopathology of hyperinflammation in COVID-19. Am J Pathol. 2021;191(1):4–17.
  • Tso WWY, Kwan MYW, Wang YL, et al. Severity of SARS-CoV-2 Omicron BA.2 infection in unvaccinated hospitalized children: comparison to influenza and parainfluenza infections. Emerg Microbes Infect. 2022;11(1):1742–1750.
  • Qiao W, Lau HE, Xie H, et al. SARS-CoV-2 infection induces inflammatory bone loss in golden Syrian hamsters. Nat Commun. 2022;13(1):2539.
  • Ling L, Chen Z, Lui G, et al. Longitudinal cytokine profile in patients with mild to critical COVID-19. Front Immunol. 2021;12:763292.
  • Mueller AA, Tamura T, Crowley CP, et al. Inflammatory biomarker trends predict respiratory decline in COVID-19 patients. Cell Rep Med. 2020;1(8):100144.
  • Sims JT, Poorbaugh J, Chang CY, et al. Relationship between gene expression patterns from nasopharyngeal swabs and serum biomarkers in patients hospitalized with COVID-19, following treatment with the neutralizing monoclonal antibody bamlanivimab. J Transl Med. 2022;20(1):134.
  • Han H, Ma Q, Li C, et al. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg Microbes Infect. 2020;9(1):1123–1130.
  • Sierra B, Perez AB, Aguirre E, et al. Association of early nasopharyngeal immune markers with COVID-19 clinical outcome: predictive value of CCL2/MCP-1. Open Forum Infect Dis. 2020;7(10):ofaa407.
  • Lee RA, Herigon JC, Benedetti A, et al. Performance of saliva, oropharyngeal swabs, and nasal swabs for SARS-CoV-2 molecular detection: a systematic review and meta-analysis. J Clin Microbiol. 2021;59(5):e02881-20.
  • Chan JF, Yip CC, To KK, et al. Improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific COVID-19-RdRp/Hel real-time reverse transcription-PCR assay validated in vitro and with clinical specimens. J Clin Microbiol. 2020;58(5):e00310-20.
  • Lucas C, Wong P, Klein J, et al. Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature. 2020;584(7821):463–469.
  • Chen LYC, Hoiland RL, Stukas S, et al. Confronting the controversy: interleukin-6 and the COVID-19 cytokine storm syndrome. Eur Respir J. 2020;56(4):2003006.
  • Hovi T, Smyth JF, Allison AC, et al. Role of adenosine deaminase in lymphocyte proliferation. Clin Exp Immunol. 1976;23(3):395–403.
  • Mantovani A, Gray PA, Van Damme J, et al. Macrophage-derived chemokine (MDC). J Leukoc Biol. 2000;68(3):400–404.
  • Vulcano M, Albanesi C, Stoppacciaro A, et al. Dendritic cells as a major source of macrophage-derived chemokine/CCL22 in vitro and in vivo. Eur J Immunol. 2001;31(3):812–822.
  • Torri A, Beretta O, Ranghetti A, et al. Gene expression profiles identify inflammatory signatures in dendritic cells. PLoS One. 2010;5(2):e9404.
  • Iellem A, Mariani M, Lang R, et al. Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. J Exp Med. 2001;194(6):847–853.
  • Yamashita U, Kuroda E. Regulation of macrophage-derived chemokine (MDC/ CCL22) production. Crit Rev Immunol. 2002;22(2):105–114.
  • Chen LL, Abdullah SMU, Chan WM, et al. Contribution of low population immunity to the severe Omicron BA.2 outbreak in Hong Kong. Nat Commun. 2022;13(1):3618.
  • Poon RW, Chan BP, Chan WM, et al. SARS-CoV-2 IgG seropositivity after the severe Omicron wave of COVID-19 in Hong Kong. Emerg Microbes Infect. 2022;11(1):2116–2119.
  • Cheng VC, Wong SC, Au AK, et al. Explosive outbreak of SARS-CoV-2 Omicron variant is associated with vertical transmission in high-rise residential buildings in Hong Kong. Build Environ. 2022;221:109323.
  • Yip CC, Sridhar S, Cheng AK, et al. Evaluation of the commercially available LightMix® modular E-gene kit using clinical and proficiency testing specimens for SARS-CoV-2 detection. J Clin Virol. 2020;129:104476.
  • To KK, Tsang OT, Leung WS, et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis. 2020;20(5):565–574.
  • Finelli L, Gupta V, Petigara T, et al. Mortality among US patients hospitalized with SARS-CoV-2 infection in 2020. JAMA Netw Open. 2021;4(4):e216556.
  • Cheng VC, Wong SC, Tong DW, et al. Multipronged infection control strategy to achieve zero nosocomial coronavirus disease 2019 (COVID-19) cases among Hong Kong healthcare workers in the first 300 days of the pandemic. Infect Control Hosp Epidemiol. 2022;43(3):334–343.
  • Zhou R, To KK, Wong YC, et al. Acute SARS-CoV-2 infection impairs dendritic cell and T cell responses. Immunity. 2020;53(4):864–877.e5.
  • Yitbarek GY, Walle Ayehu G, Asnakew S, et al. The role of C-reactive protein in predicting the severity of COVID-19 disease: a systematic review. SAGE Open Med. 2021;9:205031212110507.
  • Luo X, Zhou W, Yan X, et al. Prognostic value of C-reactive protein in patients with Coronavirus 2019. Clin Infect Dis. 2020;71(16):2174–2179.
  • Bhargava A, Fukushima EA, Levine M, et al. Predictors for severe COVID-19 infection. Clin Infect Dis. 2020;71(8):1962–1968.
  • Zaboli E, Majidi H, Alizadeh-Navaei R, et al. Lymphopenia and lung complications in patients with coronavirus disease-2019 (COVID-19): a retrospective study based on clinical data. J Med Virol. 2021;93(9):5425–5431.
  • Velavan TP, Meyer CG. Mild versus severe COVID-19: laboratory markers. Int J Infect Dis. 2020;95:304–307.
  • Wack A. Monocyte and dendritic cell defects in COVID-19. Nat Cell Biol. 2021;23(5):445–447.
  • Pérez-Gómez A, Vitalle J, Gasca-Capote C, et al. Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection. Cell Mol Immunol. 2021;18(9):2128–2139.
  • Du Z, Tian L, Jin DY. Understanding the impact of rapid antigen tests on SARS-CoV-2 transmission in the fifth wave of COVID-19 in Hong Kong in early 2022. Emerg Microbes Infect. 2022;11(1):1394–1401.
  • Wong SC, Lam GK, AuYeung CH, et al. Absence of nosocomial influenza and respiratory syncytial virus infection in the coronavirus disease 2019 (COVID-19) era: implication of universal masking in hospitals. Infect Control Hosp Epidemiol. 2021;42(2):218–221.
  • Cheng VC, Wong SC, So SY, et al. Decreased antibiotic consumption coincided with reduction in bacteremia caused by bacterial species with respiratory transmission potential during the COVID-19 pandemic. Antibiotics (Basel). 2022;11(6).
  • Cheng VC, Wong SC, Chuang VW, et al. The role of community-wide wearing of face mask for control of coronavirus disease 2019 (COVID-19) epidemic due to SARS-CoV-2. J Infect. 2020;81(1):107–114.